SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Cue Biopharma, Inc. (CUE) Reports $50.0M Q3 Net Loss vs. $7.4M

Cue Biopharma reported Q3 2026 net loss of $50.0M vs. $7.4M in Q3 2025, with revenue of $0.1M vs. $2.1M. In a prespecified high-IgE CSU subgroup, 78% on CUE-221 achieved complete hive resolution at week 12 vs. 0% on placebo.Material DetailsContext by AI AnalystThe release combines quarterly financi…

CUE

Related stories